With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative ...